A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma.
Kenta TakahashiMayu YunokawaShinsuke SasadaYae TakeharaNaoyuki MiyasakaTomoyasu KatoKenji TamuraPublished in: Journal of gynecologic oncology (2018)
The RPS system shows significant reproducibility for predicting the baseline risk of recurrence. The system could potentially impact the choice of adjuvant therapy for stage I-II endometrial carcinoma.